Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+29.4%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+29.4%/yr
vs -5.0%/yr prior
Acceleration
+34.4pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.42M | -66.7% |
| 2024 | $4.27M | -18.8% |
| 2023 | $5.25M | +701.3% |
| 2022 | $655351.00 | +142.1% |
| 2021 | $-1.56M | +53.8% |
| 2020 | $-3.37M | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $805906.00 | +445.3% |
| 2017 | $147799.00 | +4356.9% |
| 2016 | $-3472.00 | - |